Drug
Odm 216
Odm 216: highest development phase Phase 1/2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-216 NCT07805252 | Phase 1/2 | Advanced Solid Tumors Cancer |
Latest
No recent events.
Follow Odm 216 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.